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Abstract
Background: Despite global efforts to control HIV among key populations, new infections among men who have
sex with men (MSM) and transgender (TG) individuals are still increasing. The increasing HIV epidemic among
MSM/TG in China indicates that more effective services are urgently needed. However, policymakers and program
managers must have a clear understanding of MSM/TG sexual health in China to improve service delivery. To meet
this need, we undertook a scoping review to summarize HIV epidemiology and responses among MSM and TG
individuals in China.
Methods: We searched MEDLINE, EMBASE and the Cochrane Library for recent studies on MSM/TG HIV
epidemiology and responses. We also included supplemental articles, grey literature, government reports, policy
documents, and best practice guidelines.
Results: Overall, HIV prevalence among Chinese MSM was approximately 8 % in 2015 with a higher prevalence
observed in Southwest China. TG are not captured in national HIV, STD, or other sexual health surveillance systems.
There is limited data sharing between the public health authorities and community-based organizations (CBOs).
Like other low and middle income countries, China is challenged by low rates of HIV testing, linkage, and retention.
Several pilot interventions have been shown to be effective to increase HIV testing among MSM and TG individuals,
but have not been widely scaled up. Data from two randomized controlled trials suggests that crowdsourcing
contests can increase HIV testing, creating demand for services while engaging communities.
Conclusion: Improving HIV surveillance and expanding HIV interventions for Chinese MSM and TG individuals are
essential. Further implementation research is needed to ensure high-quality HIV services for MSM and TG
individuals in China.
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Background
In 2015 the WHO launched a comprehensive revision of
the 2013 consolidated ARV guidelines, recommending
immediate treatment for all people living with HIV and
pre-exposure prophylaxis (PrEP) for people at high risk
of HIV infection [1, 2]. At the same time, UNAIDS
declared that the world should end the AIDS epidemic by
2030, with the goal of achieving the 90-90-90 diagnosis
and treatment targets by 2020 [3]. Given these goals, it is
imperative that we have a better understanding of key
populations, including men who have sex with men
(MSM) and transgender individuals (TG).
Globally, MSM are 19 times more likely to be living
with HIV than the general population [4]. Despite global
efforts to control HIV among key populations, new in-
fections among MSM are still increasing [5–7]. High
HIV prevalence was consistently observed among MSM
in many regions around the world. For example in 2012,
the HIV prevalence among MSM in the Caribbean was
as high as 25 % [8]. Similar patterns have also been ob-
served in Asia [8]. TG individuals are also an important,
but often neglected, key population [9, 10].
The Chinese government has increased policy attention
to HIV in recent years, providing an opportunity to en-
hance service delivery for MSM and TG individuals [11].
The purpose of this scoping review was to summarize
HIV epidemiology and responses among MSM and TG
individuals in China.
Methods
We undertook a scoping review to summarize the MSM/
TG HIV epidemics in China, sexual health services across
the HIV care continuum, and interventions for Chinese
MSM/TG. In addition, based on the literature review, we
summarized several policy points for consideration.
We used Arksey and O’Malley’s framework for con-
ducting this scoping study. Scoping studies summarize
key evidence on a topic, but do not go through the
process of a formal systematic review [12]. We identified
studies published between January 2009 and October
2015 that reported on Chinese MSM HIV epidemiology,
sexual health services across the HIV care continuum,
and sexual health interventions. Studies were identified
using keyword searches in electronic databases. We
searched the following databases: MEDLINE (OVID inter-
face, 1946 onwards), EMBASE (OVID interface, 1947 on-
wards) and the Cochrane Library. The search string used
synonyms and variations of the following terms: MSM,
TG, meta-analysis, review and China.
We included studies that had the following elements:
1) Study designs were systematic reviews; 2) Study par-
ticipants were MSM or TG in China; and 3) Outcomes
included data on health services across the HIV care
continuum or interventions targeting Chinese MSM or
TG. If data of interest were not available in systematic
reviews, supplemental articles, grey literature, government
reports, policy documents, and best practice guidelines
were also included. We also contacted experts at the
Chinese CDC, WHO, Gates Foundation and UNAIDS to
provide reports, policy documents, and guidelines. Our
preliminary report was reviewed by civil society organiza-
tions, UN organizations, the WHO China office, and two
external reviewers.
Results
HIV epidemiology and surveillance
Population size estimation and data sharing
The WHO estimated 2–10 million MSM in China in
2009 [13]. China reported that about 2–4 % adult male
population in urban areas and 1–2 % adult male popula-
tion in rural areas are MSM, and estimated that the
number of MSM in China may range from 3.1 to 6.3
million in 2009 [14]. Another study in China estimated
that there were 5–10 million MSM in China [15].
Collected data is shared among some public health or-
ganizations and community-based organizations (CBOs).
However, most of the MSM CBOs that work closely with
local CDC have limited access to MSM health surveillance
and related data [16–18].
HIV prevalence among Chinese MSM
The HIV prevalence was estimated to be 6.0 % in 2010
[16], and it has gradually increased to 8.0 % in 2015
(Fig. 1) [19]. Regional disparity is an important feature
of the HIV epidemic among Chinese MSM. Based on a
systematic review, HIV prevalence is increasing across
all regions of China, particularly in the southwest region,
made up of five provinces [16]. The average HIV preva-
lence in this region was three times the overall Chinese
average. In addition, municipalities and provincial capi-
tals also have higher HIV prevalence, compared to other
cities [20].
Young MSM worldwide and in Asia have increased
risks of acquiring HIV and STDs [21]. In China, a study
conducted across four cities reported an HIV prevalence
of 6.7 % among MSM between 16 and 24 years old [22].
Routine HIV surveillance in China does not capture
TG individuals and most of the studies reviewed did not
mention TG individuals. One study found that 11.1 % of
transgender individuals self-reported HIV infection [23]
and another found a high burden of intimate partner
violence and risky sexual behaviors [24].
Condom use and drug use among Chinese MSM
The results from six reviews [25–30] that summarized
condom usage among Chinese MSM reveal that though
large efforts (e.g., condom promotion in venues, peer edu-
cation, and condom promotion through social media)
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have been made towards containing HIV, the overall rate
of condomless anal intercourse (CAI) is still high. Accord-
ing to one meta-analysis that included 64 articles reported
82 studies [28], the CAI (during last 6 months) rate
among Chinese MSM is about 54 % (95 % CI: 51–56 %).
Data from the Chinese surveillance system showed that
about 51 % of MSM reported engaging in CAI in the last
6 months in 2013 [19]. In addition to CAI with men,
many Chinese MSM also have condomless sex with
women. One meta-analysis that included 43 studies re-
ported that the pooled estimates condomless sex rate with
female sex partners was 74 % (95 % CI: 72–77 %) in the
last 6 months [31].
A systematic review of 33 studies reported that the drug
use rate ranged between 0.1 and 44 % among Chinese
MSM (median = 2.4 %) [27]. In China, recreational drug
use has increased considerably among MSM in recent
years [30]. A multisite cross-sectional study reported
that 28 % of MSM had used at least one kind of recre-
ational drug in the last 6 months [32]. Among MSM,
the most prevalent stimulant drugs were ecstasy and
crystal meth. Popular non-stimulant drugs include Viagra
and Ketamine [33].
HIV care continuum
Since 2008, the China MOH carried out comprehensive
AIDS responses with MSM populations in 61 cities
across China, including expanding MSM surveillance,
increasing HIV testing, case finding, and promoting link-
age to care [20]. These policies helped to define and
strengthen the HIV care continuum for MSM. Programs
for HIV testing, linkage to care, adherence, and reten-
tion have all expanded in the past 5 years.
HIV testing
Data from national HIV surveillance system illustrated
that the HIV testing rate (tested in last year) among
Chinese MSM ranged between 43.2 and 49.0 % [19]. In
addition, results from a meta-analysis of 18 studies sug-
gested that only 47 % of Chinese MSM had ever tested
for HIV, and 38 % had tested during the past 12 months
[34]. The number of surveys among young MSM indi-
cated that HIV testing rates in this group were less than
30 % [35]. In addition, among MSM tested for HIV, sev-
eral studies suggested that HIV testing is infrequent
[35–37]. One study noted poor HIV test uptake among
TG individuals in China [23].
Several research studies have identified barriers and fa-
cilitators of HIV testing among MSM. Fear of stigma
and discrimination, concerns about confidentiality, lim-
ited HIV knowledge, and institutional barriers such as
inconvenient testing times were identified as barriers to
accessing HIV testing [17, 38–40]. Practicing high risk
sexual behaviors, family and partner support, rapid test-
ing, and self-testing were mentioned as facilitators of
testing [17, 38–40].
HIV linkage to care, ARV adherence and retention in care
Nationwide scale-up of HIV treatment programs has
been implemented in China over the last decade. How-
ever, late diagnosis, incomplete linkage to care, and high
rates of loss-to-follow-up remain major clinical and pub-
lic health challenges in China [41]. Infrequent viral load
monitoring and incomplete reporting within surveillance
systems complicate more detailed analyses. Further
strengthening of the surveillance system and implementa-
tion research are needed. A study based on the national
epidemiology database reported that during 2006–2012,
21.3 % of newly diagnosed MSM did not receive CD4 cell
count testing within the 6-months following diagnosis
[42]. A online survey study reported consistent results
(74.6 % of positive individuals saw a doctor in 6 months
and 25.4 % took over 6 months to be linked to care) [43].
Multistage stepwise HIV testing and treatment initiation
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Fig. 1 HIV prevalence among Chinese MSM based on Chinese surveillance system. Source: Chinese CDC [19] and AIDSInfo
(http://www.aidsinfoonline.org/)
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procedures are major structural barriers to providing
timely antiretroviral therapy [41].
A study conducted in 2014 indicated that many
HIV-infected individuals are receiving ART that is
sub-optimal, even after they receive definite diagnosed
[44]. Among MSM patients with CD4 cell count ≤ 350
cells//mm3, only around 60 % received ART [44, 45]. A
study conducted in Guangzhou reported that among 721
adults living with HIV receiving ART, 18.9 % reported re-
cent non-adherence (any missed ART in the past 4 weeks)
and 6.8 % reported treatment interruption (4 or more
weeks of missed ART in the past year) [46].
Retention in care among MSM patients is also not op-
timal [41, 42, 44]. Based on a study conducted during
2003 to 2009, people living with HIV receiving ART re-
ported that the median length of time on ART was
18.9 months, and the cumulative probability of attrition
from ART initiation was 9 % at 12 months and 24 % at
60 months. This nationwide study showed that MSM re-
tention rates were better than other risk groups. A retro-
spective cohort study conducted in Changsha reported a
retention rate of 58.1 % at 12 months, with no difference
in retention reported between MSM and others [47].
These studies also showed that MSM face a number of
individual and structural barriers across the HIV care
continuum. Negative coping methods create significant
problems for linking newly-diagnosed men to care and
retaining them in care. Meanwhile, qualitative research
indicates that nondisclosure of sexual orientation to
families, absence peer social support and professional
psychological counseling, lack of affordable and special-
ized treatment and care, homophobia and discrimination
from providers may deter engagement in care [40, 48].
Interventions ongoing and completed
Prevention and behavioral interventions at individual and
group-level
Since 2005, the Chinese government has expanded its
intervention efforts to MSM [49]. Various programs
have been conducted to promote condom use, counsel-
ing and testing, peer education, and follow-up outreach.
A meta-analysis that summarized 22 MSM intervention
studies suggested that behavioral interventions have
been efficacious in increasing HIV knowledge, HIV test-
ing, and condom use, and in reducing sexual risk behav-
iors. However, the study also indicated that interventions
have not reduced the incidence of HIV among Chinese
MSM [50].
Interventions for promoting HIV Self-testing (HIVST) in
China
HIVST is not illegal in China, and more than 20 HIVST
kits have been approved by the Chinese Food and Drug
Administration [51] and are available in China [52].
There is currently no national program of HIVST among
MSM in China, however around one quarter of Chinese
MSM have self-tested for HIV [52, 53]. Several pilot pro-
grams have shown that HIVST is an additional HIV test-
ing method that could increase first-time HIV testing
[53, 54]. Many pilot interventions have been conducted
to examine the efficacy of hybrid CBO-clinic models in
promoting HIV testing and linkage to care (Table 1).
These interventions primarily focus on improving co-
operation among CDC system, hospital and MSM CBOs
in China [46, 55]. For example, by collaborating with a
Table 1 Project IMPACT: A Model for Increasing the
Collaboration between Community-based Organizations and
the Public Sector in China
Purpose of the program
A pilot project “Integration Minimum package of Prevention in
Accelerating Case finding and Treatment (IMPACT) was carried out in
Guangzhou since 2008. The purpose of this project was to increase the
collaboration between Community-based Organizations (CBOs) and the
public sector in China to provide friendly HIV-related service to men
who have sex with men (MSM).
Methods of the program
Guangzhou CDC and the Lingnan Partners Community Support Center
worked together to design an integrated service including HIV health
education, online HIV risk assessment, on-site HIV counseling and testing,
partner notification, CD4 cell count testing, psychosocial care and support,
and guidance on clinical treatment. This program includes three
main parts: online prevention tools, online-to-offline service linkage,
and one-stop service.
Online prevention tools: Two internet tools were developed: a scenario-based
application and an HIV risk self-assessment system. The scenario-
based application is an interactive internet application that simulates
real-life HIV risk scenarios, in order to promote HIV testing and condom
use. The online HIV risk self-assessment system evaluates an individualized
HIV-risk score by evaluating an individual’s risk profile. Based on the
results, the system provides tailored guidance to promote HIV testing and
behavioral change.
Online-to-offline service linkage: This component linked virtual intervention/
testing mobilization efforts to actual HIV testing, and facilitated HIV care.
The online prevention tools described above were linked to an online
appointment system for HIV testing. Test results were made available
online by an anonymous fication system (Easy Tell®)
One-stop shops: In ‘one-stop shops’, public sector staff provided on-site
blood sampling and testing and carried out epidemiological investigations.
Meanwhile, CBO peers delivered high-quality and timely pre- and post-test
counseling, psychosocial support services, guidance on retention to care
and ART adherence support services.
Outcomes
The IMPACT model provides services on HIV health education, online HIV
risk assessment, on-site HIV counseling and testing, partner notification,
CD4 cell count testing, psychosocial care and support, and ART adherence
guidance. The number of tests performed through IMPACT has increased
from 1,064 in 2008 to 7,754 in 2013. Of the 999 HIV positive cases identified
through this project between 2008 and 2013, linkage to care and retention
in care rates of 95 and 89 %, respectively [58].
Lessons learned
This public sector-CBO hybrid model has not only addressed the needs
of the MSM community, but has also been instrumental in reducing
barriers of access to HIV services.
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local CBO, the Guangzhou CDC built a social entrepre-
neurship model to promote HIVST among MSM [56].
Overall, 198 (52.1 %) MSM purchased self-testing kits,
and 192 (97.0 %) participants used kits and returned the
testing results [57].
Internet-based and social media interventions
A few internet-based interventions have been conducted
to improve accessibility to HIV services and care [55, 58,
59]. For example, the Guangzhou CDC developed two
internet-based interventions: ‘scenario experiencing inter-
vention application’ and ‘online HIV risk self-assessment
system’ [58]. Compared to the control group, participants
in the intervention arm of HIV risk-assessment system had
reduced CAI in the last anal sex by 44 %, and CAI with
regular and casual partners within the last three months by
26 and 25 % respectively [58].
Various social media techniques have been applied to
HIV educational interventions as well as to testing
mobilization and partner services interventions targeted
towards MSM in China. Danlan Gongyi, an LGBT on-
line web portal and CBO, used Wechat to provide rapid
and anonymous HIV testing services as well as offline
services such as psychological counseling and support
[3]. Other social media platforms, such as QQ, Jack’d
and microblogging, have been also used in carrying out
HIV/AIDS interventions among Chinese MSM [60, 61].
Crowdsourcing HIV test promotion interventions
Crowdsourcing is “the practice of obtaining needed ser-
vices, ideas, or content by soliciting contributions from a
large group of people and especially from the online
community [62].” Crowdsourcing can be used to solicit
concepts, images, and videos to promote HIV testing
(Table 2). Several crowdsourcing contests have been im-
plemented in South China. One randomized controlled
trial (RCT) in China aimed at promoting HIV testing
showed that crowdsourcing methods were both effective
and cost saving when compared to a health marketing
intervention. HIV test uptake was similar between the
crowdsourced arm (37 %, 114/307) and the health mar-
keting arm (35 %, 111/317) [52]. Another RCT in China
found that a crowdsourced intervention was non-
equivalent to a social marketing intervention, also noting
cost savings [63].
Interventions for improving linkage and retention in care
In 2012, the China CDC initiated a pilot intervention
project to demonstrate a ‘one-stop’ service model for in-
dividuals with HIV infection [44]. This model included
referral, transportation, information and emotional sup-
port. Patients in the service clinic receive all procedures
and protocols in a single setting. The pilot intervention
demonstrated that this model outperformed the existing
service model on five out of six indicators. Between 2012
and 2014, the Chinese CDC in Guangxi also piloted a pro-
gram for immediate initiation of ART [41]. The interven-
tion significantly increased ART coverage within 90 days
of diagnosis of HIV infection, and reduced overall mortal-
ity from about 26 % to less than 10 % [41].
Pre-exposure prophylaxis (PrEP)
The use of PrEP is now recommended by the WHO for
all individuals at substantial risk of acquiring HIV [64].
China has yet to make new recommendations with re-
gard to PrEP. Few studies suggest that while awareness
remains low (ranging from 2.8 to 22 %), willingness to
use PrEP is high (ranging from 64.0 to 84.6 %) [65–68].
Two PrEP demonstration projects in China have been
published to date [69, 70]. The first one compared the
effect of combination regimen of TDF + FTC daily to
TDF + FTC taken twice weekly plus an additional dose
2 h before sex. Among 153 MSM, 79.7 % completed
28 weeks of follow up, and 68.6 % reported not missing
a dose [69]. The second study allowed participants to
Table 2 SESH and crowdsourcing contests to create demand
for HIV testing and other services
Purpose of the Program
To create more engaging and effective sexual health services using
crowdsourcing and other social entrepreneurship tools.
Methods of the program
SESH has organized and evaluated several creative contributory contests
and other programs [76]. For example, in 2013, we launched our first
contest to solicit videos promoting HIV testing. First, SESH posted an
online open call for videos and hosted a call to increase awareness of
the contest. Second, a group of multisectoral judges evaluated each of
the video entries, giving them a score of 1–10 and selecting a group of
finalists and a single winner. Judging criteria included reaching
individuals who had never tested before, generating excitement, and
community responsiveness. Finally, the winner from the contest was
formally evaluated and selected as an intervention tool.
In 2014, SESH launched a sexual health image contest to encourage
young students to talk about sexual health. We promoted the contest
information as well as sexual health knowledge among young people
though online (broadcasting and interacting on wechat and weibo)
and in-person events (lectures, activities, and workshops). In 2015,
SESH launched a condom video contest to solicit videos promoting
condom use among MSM. Then in 2016 the World Health Organization
invited SESH to organize a global contest to solicit hepatitis testing
innovations [73].
Outcomes
SESH has data from RCTs, qualitative research, and social media
suggesting the effectiveness of crowdsourcing as an approach. Two RCTs
demonstrated that crowdsourcing was effective and saved money
compared to conventional evidence-based marketing approaches [52, 63].
Lesson learned
Crowdsourcing could be a useful way to spur creative, new ideas for
improving health and engaging communities. This new tool may be
especially useful in low and middle-income countries where civil society
organizations are often constrained or less able to directly inform public
health programs. Crowdsourcing contests may help create more engaging,
effective, and creative campaigns [33, 35].
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choose the no drug intervention, daily TDF or peri-
coital dosing (1 dose TDF 24–48 h before sex plus 1
dose TDF within 2 h after sex). Retention at 12 months
was relatively low (43.1 %), and varied significantly
across study arms [70].
Discussion
Based on the epidemiology and response data, we identi-
fied a number of opportunities to strengthen the HIV re-
sponse and decrease HIV risk among MSM in China.
These opportunites include improving HIV surveillance
and expanding interventions among MSM and trans-
gender individuals.
Improving HIV surveillance
Given the size and complexity of China, an accurate
MSM/TG HIV surveillance system is critical. Two areas
could improve HIV surveillance among these key popu-
lations: 1) enhancing data sharing between CBOs and
CDCs; 2) using online surveys to capture MSM and TG
individuals. Several interventions suggest the importance
of collaborative CBO-CDC programs across the con-
tinuum of care. However, MSM CBOs often have limited
access to MSM sexual health surveillance data. Increased
data sharing between CBOs and local CDCs could im-
prove service provision, needs assessment, and interven-
tion development.
Online surveys can also help capture real-time HIV
surveillance data. Large numbers of MSM in China rou-
tinely use the Internet [20], especially smart-phone based
partner-seeking mobile applications [49]. Some online
MSM are difficult to reach through the current MSM
surveillance system [23]. Integrating online data collec-
tion into the surveillance system could make it easier to
reach some subgroups of MSM. Currently, there is very
limited data specific on TG individuals. Conducting on-
line surveillance among online TG individuals could be
useful, as previous studies have shown that online sam-
pling can reduce some of the social and structural bar-
riers that limit efforts to reach TG [23, 24]. Data security
and confidentiality are important concerns in the con-
text of using online surveys.
Expanding HIV interventions for MSM and TG individuals
Our review identified a number of MSM/TG interventions
that could be expanded, including the following: 1) HIVST
interventions to expand HIV testing; 2) crowdsourcing and
social media interventions to stimulate demand for HIV
services; 3) community-based interventions.
HIVST may be a useful tool for expanding HIV testing
and promoting people-centered systems. Although
HIVST systems tailored for MSM have been piloted in
many Chinese cities [53, 57, 58], none have been widely
scaled up. Expanding the use of HIVST among MSM
represents a major opportunity for public health sys-
tems to reach MSM and TG individuals with subopti-
mal HIV test uptake. The expansion of HIVST may
require new organizations such as a social enterprise
[71] which combine elements of enterprise and social
welfare organization.
Both crowdsourcing and social media interventions
have proven effective in stimulating demand for HIV ser-
vices in China. Two randomized controlled trial studies
demonstrated that a crowdsourcing approach was effect-
ive and cost saving method among MSM and TG indi-
viduals in China [52, 63]. This method could increase
community engagement in HIV campaigns [52]. A
crowdsourcing approach could also be used to increase
demand for PrEP and partner services. In addition to
crowdsourcing, other types of social media interventions
may help to increase HIV service demand [72, 73].
Community-based interventions are an important part
of the HIV response among MSM and TG individuals.
Supporting local community-based organizations to
implement community-based interventions should be
considered. At a national and sub-national level, the
participation of key populations and key populations living
with HIV must be considered in formulating strategies
and programming [58]. Within the many CDC-CBO
hybrid models, ensuring governance and resources to
support community voices is important.
Conclusion
Implementation of HIV interventions, especially those
focused on serving MSM and TG individuals, is an enor-
mous challenge [74]. Implementation science research
can help identify and anticipate problems, and in turn,
answer questions on how best to deliver interventions
[75]. Incomplete surveillance and reporting systems, espe-
cially for TG individuals, underlines the need for strength-
ened routine surveillance and further research. This
scoping review suggests several unmet implementation
needs for MSM and TG in China.
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